PharmatecaPharmatecaФарматека2073-40342414-9128Bionika Media286673ArticlesСтатьиResearch ArticleRak molochnoy zhelezy i beremennost'Рак молочной железы и беременностьDashyanG. AДашянГ. А

д.м.н., ведущий научный сотрудник отделения опухолей молочной железы

dgarik@mail.ruSemiglazovV. FСемиглазовВ. Ф

чл. -корр. РАМН, проф., рук. отдела опухолей репродуктивной системы и отделения опухолей молочной железы

ssemiglazov@mail.ruTopuzovE. EТопузовЭ. Э

д.м.н., проф., зав. кафедрой госпитальной хирургии

eltop@inbox.ruIvanovV. GИвановВ. Г

к.м.н., зав. отделением химиотерапии опухолей молочной железы

dr.ivanov@msn.comVorotnikovV. VВоротниковВ. В

лаборант отделения опухолей молочной железы

flux.line@mail.ruLalakI. AЛалакИ. А

аспирант кафедры онкологии кафедрой онкологии

grechukhinairina@mail.ruBryantsevaZh. VБрянцеваЖ. В

аспирант кафедры онкологии

zhanna-dr@mail.ruUsungvanM. VУсунгванМ. В

аспирант кафедры госпитальной хирургии

usungvan@gmail.comTseluykoA. IЦелуйкоА. И

клинический ординатор кафедры онкологии

tselalex@rambler.ruФГБУ НИИ онкологии им. Н.Н. Петрова Минздрава РоссииГБОУ ВПО СЗГМУ им. И.И. Мечникова Минздрава РоссииГБОУ ВПО ПСПбГМУ им. акад. И.П. Павлова Минздрава России20022014214NO4 (2014)№4 (2014)182226022023Copyright ©; 2014, Bionika MediaCopyright ©; 2014, ООО «Бионика Медиа»2014Bionika MediaООО «Бионика Медиа»https://journals.eco-vector.com/2073-4034/article/view/286673

This article discusses the effectiveness of various treatments used in the treatment of breast cancer (BC), developed on the background of pregnancy, in particular surgical treatment and chemotherapy, as well as the possibility of a subsequent pregnancy and breastfeeding after treatment of breast cancer. Less favorable long-term results of treatment of patients with breast cancer that arose during pregnancy can be explained by later revealing of tumor aggravating the prognosis, as well as the influence of young age of women sick. In the treatment of breast cancer against the background of pregnancy, it is necessary to carefully follow recommendations for treatment of non-pregnant patients in most cases. Treatment strategy should be determined individually in each case, taking into account the gestational age at diagnosis, stage of disease and the preferences of patient and her family.

В статье обсуждается эффективность различных методов лечения, используемых при лечении рака молочной железы (РМЖ), развившегося на фоне беременности, в частности хирургического лечения и химиотерапии, а также возможность последующей беременности и грудного вскармливания после лечения РМЖ. Менее благоприятные отдаленные результаты лечения больных РМЖ, возникшим в период беременности, объясняются запоздалым выявлением опухоли, отягощающим прогноз заболевания, а также влиянием молодого возраста заболевших женщин. При лечении РМЖ на фоне беременности в большинстве случаев необходимо точно следовать рекомендациям по лечению небеременных больных. Тактику лечения следует определять индивидуально в каждом конкретном случае с учетом гестационного возраста на момент постановки диагноза, стадии заболевания, предпочтений больной и ее семьи.

breast cancerpregnancybreastfeedingchemotherapyрак молочной железыбеременностьгрудное вскармливаниехимиотерапияPavlidis N.A. Coexistence of pregnancy and malignancy. Oncologist. 2002;7:279-87.Cardonick E., Dougherty R., Grana G, et al. Breast cancer during pregnancy: maternal and fetal outcomes. Cancer J. 2010;16(1):76-82.Dominici L.S., Kuerer H.M., Babiera G., et al. Wound complications from surgery in pregnancy-associated breast cancer (PABC). Breast Dis. 2010;31(1):1-5.National Comprehensive Cancer Network. NCCN guidelines version 3.2012 Breast Cancer. Available at: http://www.nccn.org/professionals/physician_gls/ pdf/breast.pdf. Accessed January 15, 2013.Amant F., Loibl S., Neven P., et al. Breast cancer in pregnancy. Lancet. 2012;379(9815):570-79.Gentilini O., Cremonesi M., Toesca A., et al. Sentinel lymph node biopsy in pregnant patients with breast cancer. Eur. J. Nucl. Med. Mol. Imaging. 2010;37(1):78-83.Keleher A., Wendt R., Delpassand E., et al. The safety of lymphatic mapping in pregnant breast cancer patients using Tc-99m sulfur colloid. Breast J. 2004;10(6):492-95.Loibl S., von Minckwitz G., Gwyn K., et al. Breast carcinoma during pregnancy. International recommendations from an expert meeting. Cancer. 2006;106(2):237-46.Cohn D., Ramaswamy B., Blum K. Malignancy and pregnancy. In: Creasy R., lams J., Resnik R., eds. Maternal-fetal medicine principles and practice. 6th edition. Toronto: WB Saunders, 2010:885-904.Hahn K.M., Johnson P.H., Gordon N., et al. Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero. Cancer. 2006;107(6):1219-26.Cardonick E., Bhat A., Gilmandyar D., et al. Maternal and fetal outcomes of taxane chemotherapy in breast and ovarian cancer during pregnancy: case series and review of the literature. Ann. Oncol. 2012;23(12):3016-23.Mir O., Berveiller P., Goffinet F., et al. Taxanes for breast cancer during pregnancy: a systematic review. Ann. Oncol. 2010;21(2):425-26.Azim H.A. Jr, Santoro L., Pavlidis N., et al. Safety of pregnancy following breast cancer diagnosis: a meta-analysis of 14 studies. Eur. J. Cancer. 2011;47:74-83.Sankila R., Heinavaara S., Hakulinen T. Survival of breast cancer patients after subsequent term pregnancy: «healthy mother effect». Am. J. Obstet. Gynecol. 1994;170:818-23.Asztalos S., Gann P.H., Hayes M.K., et al. Gene expression patterns in the human breast after pregnancy. Cancer Prev. Res. (Philadelphia). 2010;3:301-11.Azim H.A. Jr, Peccatori F.A., de Azambuja E., Piccart M.J. Motherhood after breast cancer: searching for la dolce vita. Expert Rev. Anticancer Ther. 2011;11:287-98.Pagani O., Price K.N., Gelber R.D., et al. Patterns of recurrence of early breast cancer according to estrogen receptor status: a therapeutic target for a quarter of a century. Breast Cancer Res Treat. 2009;117:319-24.Jatoi I., Anderson W.F., Jeong J.H., Redmond C.K. Breast cancer adjuvant therapy: time to consider its time-dependent effects. J. Clin. Oncol. 2011;29:2301-304.Gnant M., Mlineritsch B., Stoeger H., et al. Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial. Lancet Oncol. 2011;12:631-41.Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005; 365:1687-717.Chie W.C., Hsieh C., Newcomb P.A., et al. Age at any full-term pregnancy and breast cancer risk. Am J Epidemiol 2000;151:715-22.Andrieu N., Goldgar D.E., Easton D.F., et al. Pregnancies, breast-feeding, and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS). J. Natl. Cancer Inst. 2006;98:535-44.Pagani O., Partridge A., Korde L., et al. Pregnancy after breast cancer: if you wish, ma'am. Breast Cancer Res. Treat. 2011;129:309-17.Lee S.J., Schover L.R., Partridge A.H., et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J. Clin. Oncol. 2006;24:2917-31.Anderson R.A., Cameron D.A. Pretreatment serum anti-mullerian hormone predicts longterm ovarian function and bone mass after chemotherapy for early breast cancer. J. Clin. Endocrinol. Metab. 2011;96:1336-43.Su H.I., Sammel M.D., Green J., et al. Antimullerian hormone and inhibin B are hormone measures of ovarian function in late reproductive-aged breast cancer survivors. Cancer. 2010;116:592-99.Lutchman S.K., Muttukrishna S., Stein R.C., et al. Predictors of ovarian reserve in young women with breast cancer. Br. J. Cancer. 2007;96:1808-16.Scheffer G.J., Broekmans F.J., Looman C.W., et al. The number of antral follicles in normal women with proven fertility is the best reflection of reproductive age. Hum. Reprod. 2003;18:700-6.de Bree E., Makrigiannakis A., Askoxylakis J., et al. Pregnancy after breast cancer. A comprehensive review. J. Surg. Oncol. 2010;101:534-42.Langagergaard V., Gislum M., Skriver M.V., et al. Birth outcome in women with breast cancer. Br. J. Cancer. 2006;94:142-46.Dow K.H., Harris J.R., Roy C. Pregnancy after breast-conserving surgery and radiation therapy for breast cancer. J. Natl. Cancer Inst. Monogr. 1994:131-37.Malamos N.A., Stathopoulos G.P., Keramopoulos A., et al. Pregnancy and offspring after the appearance of breast cancer. Oncology. 1996;53:471-75.Dalberg K., Eriksson J., Holmberg L. Birth outcome in women with previously treated breast cancer a population-based cohort study from Sweden. PLoS Med. 2006;3:e336.Velentgas P., Daling J.R., Malone K.E., et al. Pregnancy after breast carcinoma: outcomes and influence on mortality. Cancer. 1999; 85:2424-32.Section on Breastfeeding. Breastfeeding and the use of human milk. Pediatrics 2012; 129:e827-41.Azim A.H. Jr, de Azambuja E., Colozza M., et al. Long-term toxic effects of adjuvant chemotherapy in breast cancer. Ann. Oncol. 2011; 22:1939-47.Gelber S., Coates A.S., Goldhirsch A., et al. Effect of pregnancy on overall survival after the diagnosis of early-stage breast cancer. J. Clin. Oncol. 2001;19:1671-75.Azim H.A. Jr, Bellettini G., Liptrott S.J., et al. Breastfeeding in breast cancer survivors: pattern, behaviour and effect on breast cancer outcome. Breast. 2010;19:527-31.Azim H.A. Jr, Bellettini G., Gelber S., Peccatori F.A. Breast-feeding after breast cancer: if you wish, madam. Breast Cancer Res. Treat. 2009; 114:7-12.Higgins S., Haffty B.G. Pregnancy and lactation after breast-conserving therapy for early stage breast cancer. Cancer. 1994;73:2 1 75-80.Moran M.S., Colasanto J.M., Haffty B.G., et al. Effects of breast-conserving therapy on lactation after pregnancy. Cancer J. 2005;11:399-403.